Correspondence
- PMID: 34861661
- DOI: 10.1097/IAE.0000000000003355
Correspondence
Comment in
-
Reply.Retina. 2022 Jan 1;42(1):e11-e12. doi: 10.1097/IAE.0000000000003356. Retina. 2022. PMID: 34907130 No abstract available.
Comment on
-
SUB-RETINAL PIGMENT EPITHELIUM MULTILAMINAR HYPERREFLECTIVITY AT THE ONSET OF TYPE 3 MACULAR NEOVASCULARIZATION.Retina. 2021 Jan 1;41(1):135-143. doi: 10.1097/IAE.0000000000002815. Retina. 2021. PMID: 32282662
References
-
- Miere A, Sacconi R, Amoroso F, et al. Sub-retinal pigment epithelium multilaminar hyperreflectivity at the onset of type 3 macular neovascularization. Retina 2021;41:135–143.
-
- Augsburger M, Sarra G-M, Imesch P. Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study. Graefe's Arch Clin Exp Ophthalmol 2019;257:1889–1895.
-
- Haj Najeeb B, Deak GG, Schmidt-Erfurth UM, Gerendas BS. RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3. Br J Ophthalmol 2021;105:113–117.
Publication types
LinkOut - more resources
Full Text Sources